| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RenovoRx, Inc. | Chief Clinical Officer | Stock Option | 6,619 | 01 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNXT | RenovoRx, Inc. | 01 Jul 2025 | 1 | $0 | 4 | Chief Clinical Officer | 03 Jul 2025, 16:45 |
| RNXT | RenovoRx, Inc. | 14 Apr 2025 | 1 | $0 | 4 | Chief Clinical Officer | 16 Apr 2025, 17:18 |
| RNXT | RenovoRx, Inc. | 06 Mar 2024 | 1 | $0 | 4 | Chief Clinical Officer | 08 Mar 2024, 16:28 |
| RNXT | RenovoRx, Inc. | 01 Mar 2024 | 0 | $0 | 3 | Chief Clinical Officer | 08 Mar 2024, 16:26 |